[Potency of induced differentiation in vitro of a human promyelocytic leukemia cell mutant (HL-60-AR) with characteristics of resistance to 8-AG and deficiency in HGPRT].
D001375:Azaguanine / Q000494:pharmacology; D002454:Cell Differentiation / Q000187:drug effects; D002460:Cell Line; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D004351:Drug Resistance; D006801:Humans; D007041:Hypoxanthine Phosphoribosyltransferase / Q000172:deficiency; D007042:Hypoxanthines / Q000494:pharmacology; D015470:Leukemia, Myeloid, Acute / Q000473:pathology*; D014212:Tretinoin / Q000494:pharmacology
D007042:Hypoxanthines; D014212:Tretinoin; D007041:Hypoxanthine Phosphoribosyltransferase; D001375:Azaguanine; D004121:Dimethyl Sulfoxide